Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this same study, enhanced compound 2 potency was demonstrated by GLP-1R when its residue 332 was mutated to tryptophan, which is in contrast to the effect observed with this mutation on the potency of allosteric antagonists. It was postulated that enhanced compound 2 potency was caused by increased hydrophobic interactions between the receptor and the agonist with this mutation.”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [288]
In the citing paper
“Residues 328, 351 and 335 of GLP-1R were recently demonstrated to be important for compound 2 potency, as mutagenesis of these residues reduced compound 2 activity.288”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [288]
Citations
Cites
Molecular dynamics with coupling to an external bath
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984) · The Journal of Chemical Physics · doi:10.1063/1.448118 · Cited by 30,700
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Canonical sampling through velocity rescaling
Bussi, G., Donadio, D., & Parrinello, M. (2007) · The Journal of Chemical Physics · doi:10.1063/1.2408420 · Cited by 18,089
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., et al. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt055 · Cited by 7,473
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
Cited by
Items 101–200 of 250
Zeng, Z., Fei, L., Yang, J., Zuo, J., Huang, Z., & Li, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.783352 · Cited by 22
Ding, T., Karlov, D. S., Pino‐Ángeles, A., & Tikhonova, I. G. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00788 · Cited by 20
Saleh, N., Hucke, O., Kramer, G., Schmidt, E., Montel, F., Lipiński, R., Ferger, B., Clark, T., Hildebrand, P. W., & Tautermann, C. S. (2018) · Angewandte Chemie · doi:10.1002/ange.201708764 · Cited by 19
Kim, H., Lim, T., Ha, G. E., Lee, J., Kim, J., Chang, N., Kim, S. H., Kim, K. H., Lee, J., Cho, Y., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01082-1 · Cited by 19
A free‐energy landscape for the glucagon‐like peptide 1 receptor GLP1R
Alhadeff, R., & Warshel, A. (2019) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25777 · Cited by 19
Odoemelam, C. S., Hunter, E., Simms, J., Ahmad, Z., Chang, M., Percival, B. C., Williams, I. H., Molinari, M., Kamerlin, S. C. L., & Wilson, P. (2022) · Applied Biosciences · doi:10.3390/applbiosci1020010 · Cited by 21
Schwartz, T. W., & Frimurer, T. M. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2438 · Cited by 19
Šmelcerović, A., Lazarević, J., Tomović, K., Anastasijevic, M., Jukič, M., Kocic, G. M., & Anderluh, M. (2019) · ChemMedChem · doi:10.1002/cmdc.201800699 · Cited by 20
Wang, S., Lin, T., Peng, T., Xing, E., Chen, S., Kara, L. B., & Cheng, X. (2025) · Chemical Science · doi:10.1039/d4sc05211k · Cited by 20
Pasznik, P., Rutkowska, E. E., Niewieczerzał, S., Cielecka‐Piontek, J., & Latek, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210705 · Cited by 19
Identifying G protein-coupled receptor dimers from crystal packings
Stenkamp, R. E. (2018) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798318008136 · Cited by 18
Multisite Model of Allosterism for the Adenosine A1 Receptor
Deganutti, G., Barkan, K., Ladds, G., & Reynolds, C. A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01331 · Cited by 18
Conformational Dynamics of Glucagon-like Peptide-2 with Different Electric Field
Su, J.-J., Sun, T., Wang, Y., & Shen, Y. (2022) · Polymers · doi:10.3390/polym14132722 · Cited by 17
Self-citationGabe, M. B. N., Christensen, L. V. V., Hunt, J. E., Gadgaard, S., Gasbjerg, L. S., Holst, J. J., Kissow, H., Hartmann, B., & ROSENKILDE, M. M. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16040 · Cited by 17
Peptide recognition, signaling and modulation of class B G protein-coupled receptors
Cao, C., Zhang, H., Yang, Z., & Wu, B. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.03.008 · Cited by 19
Self-citationMutagenesis facilitated crystallization of GLP-1R
Xu, Y., Wang, Y., Wang, Y., Liu, K., Peng, Y., Yao, D., Tao, H., Liu, H., & Song, G. (2019) · IUCrJ · doi:10.1107/s2052252519013496 · Cited by 17
Self-citationWillard, F. S., Ho, J. D., & Sloop, K. W. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.02.001 · Cited by 17
Ye, X., Liu, S., Liu, Y., Qian, Z., Liu, H., Zhang, B., Guo, T., Thompson, G. J., Stevens, R. C., Sharpless, K. B., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220767120 · Cited by 17
Self-citationGIP(3-30)NH2 – a tool for the study of GIP physiology
Lynggaard, M. B., Gasbjerg, L. S., Christensen, M., & Knop, F. K. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.08.011 · Cited by 17
Exploring structure-based drug discovery of GPCRs beyond the orthosteric binding site
Chen, Z., Ren, X., Zhou, Y., & Huang, N. (2024) · hLife · doi:10.1016/j.hlife.2024.01.002 · Cited by 15
Discovery of small molecule positive allosteric modulators of the secretin receptor
Dengler, D. G., Harikumar, K. G., Pollari, S., Sun, Q. Y., Brown, B. T., Shinoki-Iwaya, A., Ardecky, R., Miller, L. J., & Sergienko, E. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114451 · Cited by 15
Energy Transport in Class B GPCRs: Role of Protein–Water Dynamics and Activation
Poudel, H., & Leitner, D. M. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c03960 · Cited by 16
Santiago, C. G., Paci, E., & Donnelly, D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.110 · Cited by 15
Drug discovery approaches targeting the incretin pathway
Deng, X., Tavallaie, M. S., Sun, R., Wang, J., Cai, Q., Shen, J., Lei, S., Fu, L., & Jiang, F. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103810 · Cited by 15
Rajappan, S. C., McCarthy, D. R., Campbell, J. P., Ferrell, J. B., Sharafi, M., Ambrozaite, O., Li, J., & Schneebeli, S. T. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006305 · Cited by 15
Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery
Mizera, M., & Latek, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084060 · Cited by 15
Redij, T., Ma, J., Li, Z., Hua, X., & Li, Z. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00254-4 · Cited by 16
Cardiovascular effects of GLP-1 receptor agonism
Winquist, R. J., & Gribkoff, V. K. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2022.02.005 · Cited by 16
Thiriet, M. (2018) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-3-319-89315-0_5 · Cited by 15
Wang, H., Hu, W., Liu, D., & Wüthrich, K. (2020) · FEBS Journal · doi:10.1111/febs.15686 · Cited by 15
Self-citationRenoprotective Effects of Incretin‐Based Therapy in Diabetes Mellitus
Yaribeygi, H., Atkin, S. L., Montecucco, F., Jamialahmadi, T., & Sahebkar, A. (2021) · BioMed Research International · doi:10.1155/2021/8163153 · Cited by 14
Progress in GPCR structure determination
Qu, X., Wang, D., & Wu, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00001-5 · Cited by 18
Self-citationLatek, D., Langer, I., Krzyśko, K. A., & Charzewski, Ł. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184348 · Cited by 13
Zhou, Q., Guo, W., Dai, A., Cai, X., Vass, M., de Graaf, C., Shui, W., Zhao, S., Yang, D., & Wang, M.-W. (2021) · Biomolecules · doi:10.3390/biom11070929 · Cited by 13
Self-citationGadgaard, S., van der Velden, W. J. C., Schiellerup, S. P., Hunt, J. E., Gabe, M. B. N., Windeløv, J. A., Boer, G. A., Kissow, H., Ørskov, C., Holst, J. J., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15766 · Cited by 13
Identification of Key Structural Motifs Involved in 7 Transmembrane Signaling of Adhesion GPCRs
Arimont, M., van der Woude, M., Leurs, R., Vischer, H. F., de Graaf, C., & Nijmeijer, S. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00051 · Cited by 12
Xia, L., Ma, Z., Tong, J., Tang, Y., Li, S., Qin, S., Lou, R., Zhao, S., Lei, X., & Shui, W. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.12.036 · Cited by 12
Self-citationYao, H., Cai, H., & Li, D. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.015 · Cited by 12
Cryo-EM reveals cholesterol binding in the lysosomal GPCR-like protein LYCHOS
Zhao, J., Shen, Q., Yong, X., Li, X., Tian, X., Sun, S., Xu, Z., Zhang, X., Zhang, L., Yang, H., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01470-9 · Cited by 11
Land, M. A., Chapman, H. L., Davis-Reyes, B. D., Felsing, D. E., Allen, J., Moeller, F. G., Elferink, L. A., Cunningham, K. A., & Anastasio, N. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53124-2 · Cited by 11
Song, S., Wang, L., Li, J., Huang, X., & Yu, R. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz045 · Cited by 10
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
Langer, I., & Latek, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.711906 · Cited by 10
Lipid Trolling to Optimize A3 Adenosine Receptor-Positive Allosteric Modulators (PAMs)
Pradhan, B., Pavan, M., Fisher, C. L., Salmaso, V., Wan, T. C., Keyes, R. F., Rollison, N., Suresh, R. R., Kumar, T. S., Gao, Z., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00944 · Cited by 12
Polymers in Physics, Chemistry and Biology: Behavior of Linear Polymers in Fractal Structures
Roman, H. E. (2024) · Polymers · doi:10.3390/polym16233400 · Cited by 11
Reubi, J. C., Fourmy, D., Cordomí, A., Tikhonova, I. G., & Gigoux, V. (2019) · Peptides · doi:10.1016/j.peptides.2019.170229 · Cited by 10
Garelja, M. L., Walker, C. A., Siow, A., Yang, S. H., Harris, P. W. R., Brimble, M. A., Watkins, H. A., Gingell, J. J., & Hay, D. L. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01180 · Cited by 10
Hu, W., Wang, H., Hou, Y., Hao, Y., & Liu, D. (2019) · FEBS Letters · doi:10.1002/1873-3468.13382 · Cited by 10
Self-citationMin, X., Yie, J., Wang, J., Chung, B. C., Huang, C.-S., Xu, H., Yang, J., Deng, L., Lin, J., Chen, Q., et al. (2020) · mAbs · doi:10.1080/19420862.2019.1710047 · Cited by 10
Paudel, P., Seong, S. H., Park, S. E., Ryu, J. H., Jung, H. A., & Choi, J. S. (2021) · Marine Drugs · doi:10.3390/md19060326 · Cited by 10
Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity
Zhang, J., Wei, J., Lai, W., Sun, J., Bai, Y., Cao, H., Guo, J., & Su, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041651 · Cited by 9
Insights into the structural dynamics of the secretin family (class B1) G protein-coupled receptors
Liu, T., Naidoo, N. R., Agyemang, E., & Lamichhane, R. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110466 · Cited by 9
Xiong, B., Wu, J., Shang, J., Chen, Y., He, Y., Zhang, X., & Tan, W. (2021) · CCS Chemistry · doi:10.31635/ccschem.021.202101541 · Cited by 9
Li, M., Zhang, X., Li, S., & Guo, J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00747 · Cited by 9
Intracellular bioorthogonal labeling of glucagon receptor via tetrazine ligation
Tian, Y., Fang, M., & Lin, Q. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116256 · Cited by 9
The Role of ICL1 and H8 in Class B1 GPCRs; Implications for Receptor Activation
Winfield, I., Barkan, K., Routledge, S. J., Robertson, N. J., Harris, M., Jazayeri, A., Simms, J., Reynolds, C. A., Poyner, D. R., & Ladds, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.792912 · Cited by 13
Allosteric modulators targeting GPCRs
López-Rodríguez, M. L., Benhamú, B., & Vázquez‐Villa, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00011-8 · Cited by 10
Disulfide‐Containing Detergents (DCDs) for the Structural Biology of Membrane Proteins
Xue, D., Xu, T., Wang, H., Wu, M., Yuan, Y., Wang, W., Tan, Q., Zhao, F., Zhou, F., Hu, T., et al. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201903190 · Cited by 10
Self-citationUniversal platform for the generation of thermostabilized GPCRs that crystallize in LCP
Schöppe, J., Ehrenmann, J., Waltenspühl, Y., & Plückthun, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00660-9 · Cited by 8
Anfinogenova, Y., Grakova, E. V., Shvedova, M., Kopeva, K. V., Teplyakov, A. T., & Popov, S. V. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9647-y · Cited by 8
Protein Design Strategies for the Structural–Functional Studies of G Protein-Coupled Receptors
Dmitrieva, D. A., Kotova, T. V., Safronova, N. A., Sadova, A. A., Dashevskii, D. E., & Mishin, A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923140110 · Cited by 7
A Chemical Strategy for Amphiphile Replacement in Membrane Protein Research
Xue, D., Wang, J., Song, X., Wang, W., Hu, T., Ye, L., Liu, Y., Zhou, Q., Zhou, F., Jiang, Z., et al. (2019) · Langmuir · doi:10.1021/acs.langmuir.8b04072 · Cited by 7
Self-citationStructural diversity in ligand recognition by GPCRs
Jakowiecki, J., Miszta, P., Niewieczerzał, S., & Filipek, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00003-9 · Cited by 8
GPCR Allostery: A View from Computational Biology
Li, M., Bao, Y., Li, M., & Guo, J. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230113125246 · Cited by 7
Zou, X., He, Y., Gao, Y., Wang, J., & Zhang, J. Z. H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146141 · Cited by 6
Watts, S. W., Townsend, R. R., & Neubig, R. R. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad121 · Cited by 6
Insights into the structure and activation mechanism of some class B1 GPCR family members
Aksu, H., Demirbilek, A., & Uba, A. İ. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09876-w · Cited by 6
Cryo‐EM Structures of Class B GPCR Reveal the Activation Mechanism
Hausch, F. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707200 · Cited by 6
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure-based drug design
O’Brien, A., Andrews, S. P., Baig, A. H., Bortolato, A., Brown, A., Brown, G. A., Brown, S. H., Christopher, J. A., Congreve, M., Cooke, R. M., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.08.015 · Cited by 6
Abbas, G., Haq, Q. M. I., Hamaed, A. M., Al-Sibani, M., & Hussain, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200131143231 · Cited by 6
Agbadaola, M. T., Hilger, D., Keller, S., & Krainer, G. (2025) · Biophysical Reviews · doi:10.1007/s12551-025-01361-3 · Cited by 6
Jariyapongskul, A., Boonsri, P., Sungwienwong, I., Dolsophon, K., Apiratikul, N., Jittangprasert, P., Sitthisuk, P., Rungsiwiwut, R., Samosorn, S., Suksamrarn, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412149 · Cited by 5
Gunta, U., Kandula, D. R., Gorti, S. K. K., Vadla, G. P., Kodiyala, G., & Mannarapu, M. (2023) · Oriental Journal Of Chemistry · doi:10.13005/ojc/390306 · Cited by 5
Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists
Chenxu, Z., Sun, L., Hu, G., Binbin, G., Wang, T., Xiaoyi, S., & Qian, L. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106818 · Cited by 5
Supramolecular oral delivery technologies for polypeptide-based drugs
Chen, J., Liu, T., Wang, M., Lü, B., Bai, D., Shang, J., Chen, Y., & Zhang, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.045 · Cited by 5
Self-citationA Structural Framework for GPCR Chemogenomics: What’s In a Residue Number?
Vass, M., Kooistra, A. J., Verhoeven, S., Gloriam, D. E. I., de Esch, I. J. P., & de Graaf, C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7465-8_4 · Cited by 5
Bartuzi, D., Wróbel, T. M., Kaczor, A. A., & Matosiuk, D. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200601155451 · Cited by 5
Assessment of Conformational State Transitions of Class B GPCRs Using Molecular Dynamics
Liao, C., May, V., & Li, J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9121-1_1 · Cited by 6
Wang, H., Hu, W., Xu, T., Yuan, Y., Liu, D., & Wüthrich, K. (2023) · iScience · doi:10.1016/j.isci.2023.106918 · Cited by 4
Self-citationMatsoukas, M.-T., Radomsky, T., Panagiotopoulos, V., Preez, R. D., Papadourakis, M., Tsianakas, K., Millar, R. P., Anderson, R. C., Spyroulias, G. A., & Newton, C. L. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00577 · Cited by 4
Dynamic States of the Ligand-Free Class A G Protein-Coupled Receptor Extracellular Side
Zhang, Q., Zhou, M., Zhao, L., Jiang, H., & Yang, H. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00146 · Cited by 4
Xiao, X., Qin, M., Zhang, F., Su, Y., Zhou, B., & Zhou, Z. (2020) · Australian Journal of Chemistry · doi:10.1071/ch20127 · Cited by 4
Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists
Zhang, X., Cai, Y., Yao, Z., Chi, H., Li, Y., Shi, J., Zhou, Z., & Sun, L. (2023) · Peptides · doi:10.1016/j.peptides.2023.170948 · Cited by 6
Fluorescent bioorthogonal labeling of class B GPCRs in live cells
Gangam, S. K., & Lin, Q. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2020.04.038 · Cited by 4
Chepurny, O. G., Matsuokas, M.-T., Liapakis, G., Leech, C. A., Milliken, B. T., Doyle, R. P., & Holz, G. G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aac119.009193 · Cited by 4
Once Blind, Now We See GLP-1 Molecular Action
Mayer, J. P., Tschöp, M. H., & DiMarchi, R. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.014 · Cited by 3
GPCRana: A web server for quantitative analysis of GPCR structures
Guo, Y., Zhou, Q., Wei, B., Wang, M.-W., & Zhao, S. (2023) · Structure · doi:10.1016/j.str.2023.06.008 · Cited by 3
Self-citationShpakov, A. O. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023070013 · Cited by 3
Rajappan, S. C., McCarthy, D. R., Campbell, J. P., Ferrell, J. B., Sharafi, M., Ambrozaite, O., Li, J., & Schneebeli, S. T. (2020) · Angewandte Chemie · doi:10.1002/ange.202006305 · Cited by 3
Is there a common allosteric binding site for G-protein coupled receptors?
Malik, F., & Li, Z. (2022) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-022-00454-5 · Cited by 3
Decrease in the efficacy of glucagon-like peptide-1 receptor agonists: what is the reason?
Кушнарьова, Н. М., Zinych, О. В., Korpachev, V. V., Ковальчук, А., Prybyla, О. В., & Shyshkan-Shyshova, К. О. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.8.2021.246799 · Cited by 3
Structure‐Based Drug Design for G Protein‐Coupled Receptors
Congreve, M., Christopher, J. A., & de Graaf, C. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc269 · Cited by 3
Crystal structure of glucagon family receptors
Crunkhorn, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.120 · Cited by 2
Rising Stars: Molecular Mechanisms of Ligand Recognition and Functional Modulation of GPCRs
Han, S., Tan, Q., Lin, S., Chen, K., He, M., Zhao, Q., & Wu, B. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169674 · Cited by 2
Self-citationRega, M., Petraglia, F. M., D’Ursi, L., Buonocore, M., Criscuolo, D., & Santoro, A. (2026) · Clinical bioenergetics · doi:10.3390/clinbioenerg2010005 · Cited by 2
Synthetic protease-activated class B GPCRs
Willard, F. S., Meredith, T. D., Showalter, A. D., Ma, W., Ho, J. D., Sauder, J. M., & Sloop, K. W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.021 · Cited by 2
Glucagon receptor family in GtoPdb v.2023.1
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2023.1 · Cited by 2
Practical Perspectives and Roles of XRD in Drug Discovery: A Review
Mehta, A., Makhija, R., Barik, P., Dhiman, S., Gupta, G. D., & Asati, V. (2024) · Current Analytical Chemistry · doi:10.2174/0115734110296435240323113938 · Cited by 2
Newly characterized crystal structures: further insights into the architecture of GPCRs
Tan, B., & Liu, M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9159-6 · Cited by 2
Shpakov, A. O. (2023) · Журнал эволюционной биохимии и физиологии · doi:10.31857/s0044452923070021 · Cited by 2
Metadata
- Authors
- Song, G., Yang, D., Wang, Y., de Graaf, C., Zhou, Q., Jiang, S., Liu, K., Cai, X., Dai, A., Lin, G., Liu, D., Wu, F., Wu, Y., Zhao, S., Ye, L., Han, G. W., Lau, J., Wu, B., Hanson, M. A., Liu, Z.-J., Wang, M.-W., & Stevens, R. C.
- Affiliations
- ShanghaiTech University (CN)
- Chinese Academy of Sciences (CN)
- Fudan University (CN)
- University of Southern California (US)
- Novo Nordisk (Denmark) (DK)
- Kunming Medical University (CN)
- Corresponding author
- Liu, Zhi-Jie
- Wang, Ming-Wei
- Stevens, Raymond C.
- ORCID
- Venue
- Nature
- Published
- 2017-05-17
- Volume
- 546
- Issue
- 7657
- Pages
- 312-315
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2616258954
- Cited by
- 241
- References
- 50
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 18 · 2023: 22 · 2022: 23 · 2021: 27 · 2020: 32 · 2019: 38 · 2018: 31 · 2017: 15
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- GLP-1 receptor, transmembrane domain structure, negative allosteric modulators, receptor activation mechanism, class B GPCRs, glucagon receptor, G protein coupling, type 2 diabetes, peptide agonists, glucagon-like peptide-1
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Protein Domains, Glucagon-Like Peptide-1 Receptor Agonists, Allosteric Regulation, Allosteric Site, Amino Acid Sequence, Aminopyridines, Benzamides, Humans, Models, Molecular, Phenylurea Compounds, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.